1/50
Comprehensive vocabulary flashcards covering cardinal signs and physiology of inflammation, tissue repair, burn classifications, Rule of Nines, and fundamental microbiology concepts from BIO 2150.
Rubor
A Latin cardinal sign of inflammation meaning redness, caused by increased blood supply to the affected tissue.
Calor
A Latin cardinal sign of inflammation meaning heat.
Tumor
A Latin cardinal sign of inflammation meaning swelling, caused by histamine release and increased permeability ('leaky' capillaries).
Dolor
A Latin cardinal sign of inflammation meaning pain, triggered when chemicals like bradykinin and cytokines activate pain receptors.
Functio Laesa
A Latin phrase meaning loss of function, sometimes added as a fifth cardinal sign of inflammation.
Pavementing
The process where neutrophils flatten out against the endothelial wall of a capillary before exiting into the tissue.
Diapedesis
The movement of leukocytes, such as neutrophils, through the capillary wall into damaged or inflamed tissue.
Chemotaxis
The migration of neutrophils toward the site of injury by following a chemical trail released by injured cells, such as bradykinin.
Opsonization
A preparatory process where bacteria are marked with chemical markers that direct neutrophils to 'chase' and engulf them.
Phagocytosis
The engulfment and digestion of a pathogen by immune cells such as neutrophils or macrophages, a process during which the neutrophil typically dies.
Superficial Burn (1st Degree)
A burn limited to the epidermis that presents as dry, red, and painful skin.
Partial Thickness Burn (2nd Degree)
A burn extending through the epidermis and into part of the dermis, characterized by skin that is red, swollen, moist, and blistered.
Full Thickness Burn (3rd Degree)
A severe burn extending through all skin layers into the hypodermis, muscle, or bone; presents charred black and is not necessarily painful due to destruction of nerves and nociceptors.

Rule of Nines
A clinical calculation used to estimate the total surface area percentage (TSA) burned across anatomical regions in adults and infants.
Primary Burn Complication
Loss of body fluids leading to severe dehydration, which takes primary clinical priority over infection.
Non-Pathogenic Microbes
Harmless, beneficial, or essential microbes living in or on the body as normal flora (such as Escherichia coli producing vitamin K in the intestines).
Opportunistic Pathogens
Microbes of the normal flora that are usually harmless but cause infection when the body's defenses are altered, such as yeast infections following antibiotic treatment.
Coccus
A round or spherical bacterial cell morphology.
Bacillus
A rod-shaped bacterial cell morphology.
Vibrio
A curved rod-shaped bacterial cell morphology.
Endotoxin
A toxin located within a bacterial cell that is released only when the bacterial cell dies and lyses.
Exotoxin
A toxic bacterial waste product that is actively secreted while the bacterium is alive.
Bacterial Endospore
A dormant, highly resistant structure adopted by certain bacteria (such as Bacillus anthracis) to survive harsh environmental conditions.
Clostridium tetani
The bacterial pathogen causing tetanus ('lock-jaw'), producing sustained full muscle contractions strong enough to break bones.
In Vivo
Biological processes, phenomena, or testing taking place inside a living organism ('life').
In Vitro
Biological procedures or experiments conducted outside a living organism in an artificial environment such as glassware or a petri dish ('glass').
First Line of Defense
The body's innate, non-specific physical and chemical surface barriers that prevent pathogen entry, including the skin, mucous membranes, and bodily secretions.
Second Line of Defense
The innate, non-specific internal cellular and chemical defenses activated once a barrier is breached, including phagocytosis, inflammation, fever, and antimicrobial proteins.
Third Line of Defense
The adaptive, specific immune response that recognizes and targets specific foreign antigens while developing immunological memory, mediated by specialized lymphocytes.
Antigen
A foreign molecule or surface marker capable of binding to immune receptors and eliciting an adaptive immune response.
Cell-Mediated Immunity
An adaptive immune response driven by T-lymphocytes that directly targets and destroys infected host cells, intracellular pathogens, and abnormal cells.
Humoral Immunity
An adaptive immune response mediated by B-lymphocytes that secrete circulating antibodies to neutralize extracellular toxins and pathogens.
Helper T Cells (CD4+)
Lymphocytes that orchestrate the adaptive immune response by secreting cytokines that activate B-lymphocytes, cytotoxic T cells, and macrophages.
Cytotoxic T Cells (CD8+)
Effector lymphocytes that directly recognize and kill virus-infected cells, intracellular parasites, and tumor cells via apoptotic mechanisms.
Immunoglobulin G (IgG)
The most abundant antibody in circulation, effective in secondary immune responses and capable of crossing the placenta to protect a developing fetus.
Immunoglobulin A (IgA)
A dimeric antibody concentrated in mucosal secretions, saliva, tears, and breast milk that blocks pathogen adherence to epithelial linings.
Immunoglobulin M (IgM)
A large pentameric antibody that serves as the initial responder in a primary immune response and excels at agglutination and complement activation.
Immunoglobulin E (IgE)
An antibody class that binds to mast cells and basophils, triggering rapid degranulation and histamine release during allergic and antiparasitic reactions.
Immunoglobulin D (IgD)
An antibody class attached to the cell membrane of naive B-lymphocytes, functioning primarily as an antigen receptor involved in cellular activation.
Natural Active Immunity
Adaptive immunity acquired when an individual naturally encounters a pathogen, develops clinical or subclinical illness, and synthesizes endogenous antibodies and memory cells.
Artificial Active Immunity
Adaptive protection gained when an individual is vaccinated with weakened, dead, or recombinant antigens to stimulate memory cell formation without causing disease.
Natural Passive Immunity
Short-term adaptive protection conferred naturally when maternal antibodies are transferred to a fetus across the placenta or to an infant through breast milk.
Artificial Passive Immunity
Immediate, transient protection achieved by injecting a recipient with exogenous antibodies or antitoxins harvested from an outside donor.
Type I Hypersensitivity
An immediate allergic reaction triggered when an allergen cross-links pre-existing IgE antibodies on mast cells, causing sudden degranulation and mediator release.
Type II Hypersensitivity
A cytotoxic immune reaction in which antibodies (IgG or IgM) bind directly to target antigens on cell surfaces, resulting in complement-mediated cell lysis or phagocytosis.
Type III Hypersensitivity
An immune complex disorder wherein soluble antigen-antibody lattices deposit within vascular walls and tissue beds, eliciting intense localized inflammation.
Type IV Hypersensitivity
A cell-mediated, delayed reaction driven by sensitized T-lymphocytes releasing inflammatory cytokines, manifesting clinically 24 to 72 hours following antigen exposure.
Anaphylaxis
A sudden, severe, and potentially fatal systemic Type I hypersensitivity reaction marked by widespread vasodilation, airway bronchospasm, and circulatory collapse.
Systemic Lupus Erythematosus (SLE)
A chronic multisystem autoimmune disease marked by autoantibodies against nuclear components, causing widespread immune complex formation and tissue destruction.
Human Immunodeficiency Virus (HIV)
An enveloped retrovirus that infects and progressively depletes helper T cells (CD4+), disabling both cellular and humoral immune function.
Acquired Immunodeficiency Syndrome (AIDS)
The late, life-threatening stage of retroviral infection defined by profound immune suppression, opportunistic infections, and a helper T cell count under 200 cells/mm3.